Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2196
https://www.valueinhealthjournal.com/article/S1098-3015(14)04126-6/fulltext
Title :
Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04126-6&doi=10.1016/j.jval.2014.08.2196
First page :
A620
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1652